Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway. [electronic resource]
Producer: 20040420Description: 757-61 p. digitalISSN:- 0022-1767
- Animals
- CD4-Positive T-Lymphocytes -- immunology
- Cell Line, Tumor
- Cytotoxicity, Immunologic -- genetics
- Graft Rejection -- immunology
- Immunity, Cellular -- genetics
- Immunity, Innate -- genetics
- Immunization, Secondary
- Immunologic Memory -- genetics
- Injections, Subcutaneous
- Killer Cells, Natural -- immunology
- Lymphoma, T-Cell -- immunology
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- NK Cell Lectin-Like Receptor Subfamily K
- Neoplasm Transplantation
- Receptors, Immunologic -- physiology
- Receptors, Natural Killer Cell
- T-Lymphocytes, Regulatory -- immunology
- Th1 Cells -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.